Bioverativ
BIVVCompletedSpin of Bioverativ (BIVV) hemophilia business
- Distribution date
- 1 Feb 2017
- Structure
- Spin-off
- Parent
- Biogen (BIIB)
- Spin-off ticker
- BIVV
- 2-year mark
- 1 Feb 2019
- Market
- United States
Section 355 clock. Two years from the distribution, an acquirer can generally step in without putting the tax-free status at risk.Window passed
1 Feb 2017100%1 Feb 2019
Source documents
- Press releaseCompletion release (02/01/17)
- PresentationInvestor day presentation (01/17)
- Information statementInformation statement
Every Spin-Off research
No report on this situation yet. New reports are published on Substack first.
Receive reports by email